Costi  Sifri

Costi Sifri, MD

Division:
Infectious Diseases and International Health
Department:
Medicine
Call 434.982.1700
Primary Location:
Transplant Center

Fourth Floor

1300 Jefferson Park Ave.

Charlottesville, VA 22903

Directions
Phone:
434.982.1700
Expertise
ABMS Certification:
Internal Medicine, 1998; Infectious Disease, 2000
Research Interests:

Bacterial pathogenesis, healthcare-associated infections, hospital epidemiology, host-pathogen interactions, innate immunity, Legionella, multidrug resistance, Staphylococci

Clinical Practice:
Meningitis (Bacterial and Viral)-child, Tinea Capitis (Scalp Infection), Genital Herpes, Gonorrhea, Hepatitis A, Hepatitis B, Hepatitis C, HIV Infection and AIDS, Influenza, Lyme Disease, Measles, Epidemic Parotitis (Mumps), Onychomycosis, Osteomyelitis (Bone Infection), Syphilis, Tuberculosis (TB), Genital Warts, Pneumonia, Methicillin-Resistant Staph Infection (MRSA), Infectious Diseases
About
Title:
Associate Professor of Internal Medicine; Hospital Epidemiologist
Biography

Costi Sifri, MD, is the director of hospital epidemiology at UVA. He works to prevent and control hospital infections to protect patients and health care providers. He is also the medical director of the transplant and compromised host infectious disease service, and an associate professor in the Division of Infectious Diseases and International Health.

Born in Gresham, Oregon, Dr. Sifri earned his BS in biochemistry from the University of Oregon in Eugene. After graduating from medical school at the University of Rochester, he did his residency in internal medicine at the University of Pennsylvania in Philadelphia. He then moved to Boston for a combined clinical and research fellowship in infectious disease at Harvard Medical School, the Massachusetts General Hospital and Brigham & Women’s Hospital. He joined UVA in 2004. In 2015, he was recognized by the School of Medicine for excellence in clinical care.

Dr. Sifri has an active research agenda focused on understanding the molecular epidemiology of dissemination of multidrug resistant organisms (MDROs) in the healthcare environment. He is also interested in understanding the clinical consequences of MDRO infections and identifying effective methods to limit or curtail the spread of resistant organisms and determinants.

Awards
  • 2015-2018 Best Doctors in America® List 
  • 2015 Bedside Manner Award, Our Health Magazine; First place 
Education
Primary:
University of Rochester, 1995
Residency:
Internal Medicine, Hospital of the University of Pennsylvania
Fellowships:
Infectious Disease, Massachusetts General Hospital and Brigham and Women's Hospital